Indomethacin Extended-Release Capsules and Mogamulizumab-kpkc Intravenous
Determining the interaction of Indomethacin Extended-Release Capsules and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indomethacin
Brand name: Indocin, Indocin SR, Tivorbex
Synonyms: Indomethacin
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indomethacin Extended-Release Capsules-Molindone
- Indomethacin Extended-Release Capsules-Mometasone (Oral Inhalation)
- Indomethacin Extended-Release Capsules-Mometasone and Formoterol
- Indomethacin Extended-Release Capsules-Mometasone and formoterol Inhalation
- Indomethacin Extended-Release Capsules-Mometasone Cream
- Indomethacin Extended-Release Capsules-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Indomethacin Injection
- Mogamulizumab-kpkc Intravenous-Indomethacin Intravenous
- Mogamulizumab-kpkc Intravenous-Indomethacin Rectal
- Mogamulizumab-kpkc Intravenous-Indomethacin Suppositories
- Mogamulizumab-kpkc Intravenous-Indomethacin Suppository
- Mogamulizumab-kpkc Intravenous-Indomethacin Suspension